BullFrog AI Holdings, Inc. financial data

Symbol
BFRG, BFRGW on Nasdaq
Industry
Pharmaceutical Preparations
Location
325 Ellington Blvd., Unit 317, Gaithersburg, MD
State of incorporation
Nevada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 955 %
Return On Equity -131 % +68.9%
Return On Assets -117 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.85M shares +28.8%
Common Stock, Shares, Outstanding 7.85M shares +28.8%
Entity Public Float 11.7M USD
Common Stock, Value, Issued 79 USD +29.5%
Weighted Average Number of Shares Outstanding, Basic 8.12M shares +34.2%
Weighted Average Number of Shares Outstanding, Diluted 8.12M shares +34.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 65K USD
Revenue from Contract with Customer, Excluding Assessed Tax 65K USD
Cost of Revenue 5.2K USD
Research and Development Expense 1.85M USD +120%
General and Administrative Expense 4.49M USD +44.2%
Operating Income (Loss) -6.29M USD -59.1%
Nonoperating Income (Expense) 222K USD +24.3%
Net Income (Loss) Attributable to Parent -6.07M USD -42.2%
Earnings Per Share, Basic -0.84 USD/shares +8.7%
Earnings Per Share, Diluted -0.84 USD/shares +16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.61M USD +2.83%
Assets, Current 6.07M USD +0.6%
Property, Plant and Equipment, Net 5.11K USD -25.2%
Assets 6.08M USD +0.57%
Accounts Payable, Current 82K USD -83.3%
Accrued Liabilities, Current 268K USD +37%
Liabilities, Current 691K USD -39.4%
Liabilities 691K USD
Retained Earnings (Accumulated Deficit) -13.3M USD -84.4%
Stockholders' Equity Attributable to Parent 5.39M USD +9.89%
Liabilities and Equity 6.08M USD +0.57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.9M USD +19.5%
Net Cash Provided by (Used in) Financing Activities 6.29M USD -18.6%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 7.85M shares +28.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.39M USD -18.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.61M USD +2.83%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.27K USD -96.1%
Deferred Tax Assets, Valuation Allowance 2.07M USD +124%
Deferred Tax Assets, Gross 2.07M USD +124%
Depreciation 431 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 1.43M USD +55%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 18.7M USD +54.2%
Deferred Tax Assets, Net of Valuation Allowance 452 USD
Interest Expense 22.1K USD -94.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%